Status:
COMPLETED
Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma
Lead Sponsor:
Indonesia University
Conditions:
Oral Squamous Cell Carcinoma
Neoadjuvant Chemotherapy
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Backgrounds Squamous cell carcinoma of the oral cancer (OSCC) is the sixth most common malignancy. Surgery is the mainstay of treatment for oral cancers. In locally advanced and unresectable oral can...
Eligibility Criteria
Inclusion
- Patients with locally advanced oral squamous cell carcinoma
- Patients with locally advanced oral squamous cell carcinoma who are planned with neoadjuvant chemotherapy
- Patients with locally advanced oral squamous cell carcinoma who are planned with neoadjuvant chemotherapy who have not received any definitive treatment modalities, including surgical resection and chemoradiation therapy before the study conducted
- Patients who are willing to sign the informed consent form to be our subject participants
- Karnofky \>50
Exclusion
- Patients who are already treated with definitive therapy for locally advanced oral squamous cell carcinoma
- Patients who are not eligible to be treated with chemotherapy
Key Trial Info
Start Date :
July 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04137627
Start Date
July 4 2017
End Date
December 18 2018
Last Update
December 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Universitas Indonesia
Jakarta Pusat, DKI Jakarta, Indonesia, 10430